Rallying to the Challenge 2024 - Day 1
Thomas Goralski, Van Andel Institute

Thomas Goralski, a PhD candidate at Van Andel Institute, gives an overview of the aggregation of proteins, specifically alpha-synuclein, in Parkinson's and how this contributes to progression of the condition. Thomas also discusses his ongoing research which aims to identify which cells are most vulnerable to this pathology and how we can use these learnings to inform future treatments.

This talk was given as a part of the Rallying to the Challenge meeting, hosted by Cure Parkinson's and the Van Andel Institute in Grand Rapids, Michigan on September 23-24, 2024. Rallying to the Challenge is a meeting designed for and by people with Parkinson’s, advocates, and care partners to explore how the Parkinson’s community can impact and accelerate research. It is a part of the larger Grand Challenges in Parkinson's Disease meeting, an annual scientific symposium for Parkinson's research.